The FDA Has Approved A New Alzheimer’s Drug — Here’s Why That’s Controversial

(By Scott Hensley, Jon Hamilton, and Laurel Wamsley for NPR)

The Food and Drug Administration approved the drug aducanumab to treat patients with Alzheimer’s disease on Monday. It is the first new drug approved by the agency for Alzheimer’s disease since 2003.  Continue reading the article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org